Hans Lennart Rudolf Wigzell

Dr. Hans Lennart Rudolf Wigzell is an Independent Director at Sarepta Therapeutics, Inc., a Chairman at RaySearch Laboratories AB, a Chairman at Biochromix Newco AB, a Chairman at PRFA Management AB, a Chairman at Stockholm School of Entrepreneurship, a Member at American Academy of Arts & Sciences, a Member at European Molecular Biology Organization, a Member at Finnish Society of Sciences & Letters, a Member of Royal Danish Academy of Sciences & Letters, a Member at Royal Swedish Academy of Engineering Sciences and a Member at Royal Swedish Academy of Sciences.
He is on the Board of Directors at Sarepta Therapeutics, Inc., Gapminder Foundation, Humabs LLC and Wigzellproduktion AB. Dr. Wigzell was previously employed as an Independent Member-Supervisory Board by Valneva SE, a Member-Supervisory Board by Probi AB, a Chairman by Karolinska Development AB, an Independent Director by Swedish Orphan Biovitrum AB, a Founder by Affibody Medical AB, a President by Karolinska Institutet, a General Director by National Bacteriological Laboratory, a Member-Supervisory Board by Biovitrum AB, a Member-Supervisory Board by Epixis SA, a Chairman by ExThera AB, a Chairman by Rhenman & Partners Asset Management AB, and a General Director by Smittskyddsinstitutet.
He also served on the board at Cadila Pharmaceuticals Sweden AB, Intercell AG, Mertiva AB and NeoDynamics AB. He received his doctorate degree from Karolinska Institutet.